There are large accumulations of plastics in the ocean, even outside so-called garbage patch

Neuston net towed on the side of the German RV SONNE, collecting surface-floating plastic samples when crossing the North Pacific Ocean.
Photo Credit: Philipp Klöckner / UFZ

When plastic ends up in the ocean, it gradually weathers and disintegrates into small particles. If marine animals ingest these particles, their health can be severely affected. Large accumulations of plastic can therefore disrupt the biological balance of marine ecosystems. But which areas are particularly affected? In a recent study, a research team from the Helmholtz Centre for Environmental Research (UFZ), in collaboration with the Alfred Wegener Institute Helmholtz Centre for Polar and Marine Research (AWI), has found large quantities of plastic waste and microplastics in a remote marine protected area in the Pacific Ocean. These quantities were similar to those found in one of the world’s largest known garbage patches. The researchers highlight that plastics are distributed much more widely than expected. The entire ocean ecosystem is threatened. They therefore call for the global emissions of plastics into the ocean to be stopped as quickly as possible. The study has been published in Environmental Science & Technology.

New research deepens our understanding of pescatarians

(L-R)
Postgraduate researcher Maja Cullen, teaching assistant and researcher Devon Docherty, and Dr Carol Jasper
Photo Credit: Courtesy of University of Stirling

New research has deepened our understanding of why pescatarians choose to eat fish but not the meat of land animals.

The perceived distance between marine life and participants in the study was a key factor, researchers in the University of Stirling’s Division of Psychology found.

The team, consisting of Maja Cullen, Devon Docherty and Dr Carol Jasper, used the construal-level theory of psychological distance to investigate further how this distance is created and how this might be experienced.

The theory argues that we interpret people, animals, objects or situations differently depending on how much we know about them.

Dr Carol Jasper, co-author of the study, said: “When we do not know much about someone or something we think of it in more abstract and general terms because we lack information.

“For our sample of pescatarians, this meant that they felt less emotionally connected to marine animals than they felt to land animals with whom we share some more obvious similarities.

A protein found in human sweat may protect against Lyme disease

Human sweat contains a protein that may protect against Lyme disease, according to a study from MIT and the University of Helsinki. About one-third of the population carries a genetic variant of this protein that is associated with Lyme disease in genome-wide association studies.
Photo Credit: Erik Karits

Lyme disease, a bacterial infection transmitted by ticks, affects nearly half a million people in the United States every year. In most cases, antibiotics effectively clear the infection, but for some patients, symptoms linger for months or years.

Researchers at MIT and the University of Helsinki have now discovered that human sweat contains a protein that can protect against Lyme disease. They also found that about one-third of the population carries a genetic variant of this protein that is associated with Lyme disease in genome-wide association studies.

It’s unknown exactly how the protein inhibits the growth of the bacteria that cause Lyme disease, but the researchers hope to harness the protein’s protective abilities to create skin creams that could help prevent the disease, or to treat infections that don’t respond to antibiotics.

“This protein may provide some protection from Lyme disease, and we think there are real implications here for a preventative and possibly a therapeutic based on this protein,” says Michal Caspi Tal, a principal research scientist in MIT’s Department of Biological Engineering and one of the senior authors of the new study.

Hanna Ollila, a senior researcher at the Institute for Molecular Medicine at the University of Helsinki and a researcher at the Broad Institute of MIT and Harvard, is also a senior author of the paper, which appears today in Nature Communications. The paper’s lead author is Satu Strausz, a postdoc at the Institute for Molecular Medicine at the University of Helsinki.

Fighting heart attack down to the smallest vessels

Graphical Abstract of drug infusion for MVO treatment via regular vs. balloon catheter.
Image Credit: © ARTORG Center

Researchers in Bern have co-developed and tested a new method to combat the blockage of tiny coronary arteries after a heart attack. The new approach, born from a cooperation of engineers, clinicians, and industry, offers a treatment option to prevent the death of heart tissue after a heart attack, responsible for poor long-term patient health.

In myocardial infarction (heart attack), the supply of the heart muscle with oxygen and nutrients is blocked by an obstruction of a major coronary artery. Even after recanalization of this artery via stent, secondary obstructions in the cardiac microcirculation (Microvascular Obstruction, MVO) occur in 40-60% of all patients. This can lead to the death of heart tissue, with a negative impact on the long-term cardiovascular health of patients. Around 200,000 people are affected by this in Switzerland every year.

UC Irvine-led research team discovers role of key enzymes that drive cancer mutations

“Both APOBEC3A and APOBEC3B were known to generate mutations in many kinds of tumors, but until now we did not know how to identify the specific type caused by each,” says the study’s corresponding author, Rémi Buisson (center), UCI assistant professor of biological chemistry. He’s flanked by postdoctoral fellow Pedro Ortega (left) and graduate student Ambrocio Sanchez, UCI researchers who developed a new method to characterize the particular kind of DNA modified by the enzymes.
Photo Credit: UCI School of Medicine

A research team led by the University of California, Irvine has discovered the key role that the APOBEC3A and APOBEC3B enzymes play in driving cancer mutations by modifying the DNA in tumor genomes, offering potential new targets for intervention strategies.

The study, published today online in the journal Nature Communications, describes how the researchers identified the process by which APOBEC3A and APOBEC3B detect specific DNA structures, resulting in mutations at distinct positions within the tumor genome.

“It’s critical to understand how cancer cells accumulate mutations leading to hot spots that contribute to disease progression, drug resistance and metastasis,” said corresponding author Rémi Buisson, UCI assistant professor of biological chemistry. “Both APOBEC3A and APOBEC3B were known to generate mutations in many kinds of tumors, but until now we did not know how to identify the specific type caused by each. This finding will allow us to develop novel therapies to suppress mutation formation by directly targeting each enzyme accordingly.”

Bridge in a box: Unlocking origami’s power to produce load-bearing structures

From left, Yi Zhu, a Research Fellow in Mechanical Engineering, and Evgueni Filipov, an associate professor in both Civil and Environmental Engineering and Mechanical Engineering, working in his lab in the George G. Brown Laboratories Building.
Image Credit: Brenda Ahearn/University of Michigan, College of Engineering, Communications and Marketing

For the first time, load-bearing structures like bridges and shelters can be made with origami modules—versatile components that can fold compactly and adapt into different shapes—University of Michigan engineers have demonstrated.

It’s an advance that could enable communities to quickly rebuild facilities and systems damaged or destroyed during natural disasters, or allow for construction in places that were previously considered impractical, including outer space. The technology could also be used for structures that need to be built and then disassembled quickly, such as concert venues and event stages.

“With both the adaptability and load-carrying capability, our system can build structures that can be used in modern construction,” said Evgueni Filipov, an associate professor of civil and environmental engineering and of mechanical engineering, and a corresponding author of the study in Nature Communications.

Principles of the origami art form allow for larger materials to be folded and collapsed into small spaces. And with modular building systems gaining wider acceptance, the applications for components that can be stored and transported with ease have grown.

New strategy to facilitate muscle regeneration after injury

From left to right, Ginés Viscor, Joan Ramon Torrella and Garoa Santocildes.
Photo Credit: Courtesy of University of Barcelona

Muscle injuries are common in the active population, and they cause the majority of player leaves in the world of sport. Depending on the severity, recovery of muscle function is quite slow and may require surgery, medication and rehabilitation. Now, a study led by the University of Barcelona reveals a strategy to improve and accelerate recovery from muscle injuries that has potential application in the sports and health sector in general.

This is the first study to provide scientific evidence for faster and more effective recovery from muscle injuries through intermittent exposure to low oxygen availability (hypoxia) in a low-barometric pressure (hypobaric) chamber that simulates high-altitude geographic conditions.

The new approach is important for the recovery of athletes — especially in the competitive elite — but also to mitigate the socio-economic impact of the loss of work productivity caused by these injuries on the active population.

The study, carried out with animal models, has been published in the Journal of Physiology. The authors of the study are the experts Garoa Santoildes, Teresa Pagès, Joan Ramon Torrella and Ginés Viscor, from the Department of Cell Biology, Physiology and Immunology of the UB’s Faculty of Biology.

All creatures great and small: Sequencing the blue whale and Etruscan shrew genomes

Prompts by Scientific Frontline
Image Credit: AI Generated by Copilot / Designer / DALL-E 3

The blue whale genome was published in the journal Molecular Biology and Evolution, and the Etruscan shrew genome was published in the journal Scientific Data.

Research models using animal cell cultures can help navigate big biological questions, but these tools are only useful when following the right map.

“The genome is a blueprint of an organism,” says Yury Bukhman, first author of the published research and a computational biologist in the Ron Stewart Computational Group at the Morgridge Institute, an independent research organization that works in affiliation with the University of Wisconsin–Madison in emerging fields such as regenerative biology, metabolism, virology and biomedical imaging. “In order to manipulate cell cultures or measure things like gene expression, you need to know the genome of the species — it makes more research possible.”

The Morgridge team’s interest in the blue whale and the Etruscan shrew began with research on the biological mechanisms behind the “developmental clock” from James Thomson, emeritus director of regenerative biology at Morgridge and longtime professor of cell and regenerative bBiology in the UW School of Medicine and Public Health.  It’s generally understood that larger organisms take longer to develop from a fertilized egg to a full-grown adult than smaller creatures, but the reason why remains unknown.

“It’s important just for fundamental biological knowledge from that perspective. How do you build such a large animal? How can it function?” says Bukhman.

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

Photo Credit: Accuray

A team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combination of a short course of powerful and intense hormonal therapy with targeted radiation is safe and effective in treating people with prostate cancer that has come back and has spread to other parts of the body.

In the small study, researchers found that 50% of the patients who were treated with the combination therapy had no signs of the cancer and remained free of recurrence six months after their treatment, with less than a quarter experiencing severe side effects from the treatment. 

“In contrast, without this combined treatment approach, we would expect approximately 1% of patients to have no evidence of disease at the six-month stage,” said Dr. Amar Kishan, professor of radiation oncology at the David Geffen School of Medicine at UCLA and senior author of the study. “These results suggest a substantial improvement and strongly suggest there can be a meaningful impact —namely, delaying the need for hormonal therapy and thus without the significant side effects of it— by attacking metastatic prostate cancer early.”

The results were published in the journal of European Urology.

Nearly all men who are diagnosed with metastatic hormone-sensitive prostate cancer are treated with androgen deprivation therapy, a type of hormonal therapy that aims to lower the levels of male hormones called androgens that can stimulate the growth of prostate cancer cells. 

Bioengineers manage a first: measuring pH in cell condensates

Researchers were able to measure pH in a type of condensate called the nucleolus, the site of ribosome production. They report that the distinct protein compositions of nucleoli give them an acidic character.
 Image Credit: Matthew King

Scientists trying to understand the physical and chemical properties that govern biomolecular condensates now have a crucial way to measure pH and other emergent properties of these enigmatic, albeit important cellular compartments.

Condensates are communities of proteins and nucleic acids. They lack a membrane and come together and fall apart as needed. The nucleolus is a prominent condensate in cells. It serves vital roles in cellular physiology and is the site of ribosome production.

Ribosomes are the multi-protein and RNA assemblies where the genetic code is translated to synthesize proteins. Impairment of ribosome production and other nucleolar dysfunctions lie at the heart of cancers, neurodegeneration and developmental disorders.

In a first for the condensate field, researchers from the lab of Rohit Pappu, the Gene K. Beare Distinguished Professor of biomedical engineering, and colleagues in the Center for Biomolecular Condensates in the McKelvey School of Engineering at Washington University in St. Louis, figured out how nucleolar substructures are assembled. This organization gives rise to unique pH profiles within nucleoli, which they measured and compared with the pH of nearby non-nucleolar condensates including nuclear speckles and Cajal bodies.